Related Experiment Video
Updated: Aug 11, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Interaction of clavulanate with class C beta-lactamases
1Centre d'Ingénierie des Protéines and Laboratorie d'enzymologie, Université de Liège, Belgium.
Clavulanate shows poor efficiency in inactivating class C enzymes due to slow protein acylation and high turnover rates, leading to branched reaction pathways and low reactivation. This detailed study offers insights into enzyme inhibition mechanisms.
Area of Science:
- Biochemistry
- Enzyme kinetics
- Drug discovery
Background:
- Class C enzymes are crucial in bacterial resistance.
- Understanding their inhibition is key to developing new antibiotics.
- Clavulanate is a known beta-lactamase inhibitor.
Purpose of the Study:
- To investigate the detailed interactions between clavulanate and three distinct class C enzymes.
- To elucidate the reaction mechanisms and kinetics of this inhibition process.
- To identify the factors contributing to clavulanate's efficiency as an enzyme inactivator.
Main Methods:
- Enzyme assays to monitor activity over time.
- Kinetic analysis to determine reaction rates and pathways.
- Spectroscopic methods to study enzyme-inhibitor interactions.
Main Results:
- Reactions followed branched pathways with 25-150 turnovers before complete inactivation.
- Observed low reactivation rates for the enzyme-clavulanate complex.
- Identified very slow protein acylation and a relatively high turnover rate as key factors for clavulanate's poor efficiency.
Conclusions:
- Clavulanate's inefficiency as a class C enzyme inactivator is attributed to slow acylation and high turnover.
- The observed branched pathways and low reactivation rates highlight complex inhibition kinetics.
- Findings provide a basis for designing more effective class C enzyme inhibitors.
Related Concept Videos
Antimicrobial Effectiveness
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial DNA Synthesis
Clinical Significance of Antibiotic Resistance

